Cabaletta Bio (CABA) Enterprise Value (2018 - 2025)

Cabaletta Bio's Enterprise Value history runs 8 years deep, the most recent figure standing at -$133.6 million for Q4 2025.

• In Q4 2025, Enterprise Value rose 18.52% year-over-year to -$133.6 million; the TTM figure through Dec 2025 stood at -$133.6 million (up 18.52% YoY), while the FY2025 annual figure was -$133.6 million, up 18.52% from the prior year.
• Enterprise Value was -$133.6 million for Q4 2025 at Cabaletta Bio, up from -$159.9 million in the prior quarter.
• In the past five years, Enterprise Value ranged from a high of -$93.8 million in Q1 2023 to a low of -$272.4 million in Q1 2024.
• Historically, Enterprise Value has averaged -$161.5 million across 5 years, with a median of -$152.7 million in 2022.
• The sharpest annual moves came in 2024 and 2025: Enterprise Value tumbled 190.26% in 2024, then surged 51.6% in 2025.
• A 5-year view of Enterprise Value shows it stood at -$122.2 million in 2021, then grew by 12.83% to -$106.5 million in 2022, then slumped by 126.42% to -$241.2 million in 2023, then jumped by 32.04% to -$164.0 million in 2024, then increased by 18.52% to -$133.6 million in 2025.
• The last three Enterprise Value figures came in at -$133.6 million (Q4 2025), -$159.9 million (Q3 2025), and -$194.7 million (Q2 2025), per Business Quant data.